News

Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.

nanoparticles, stroke, tPA, blood clot, magnetic, MRI, antiplatelet

By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly...

Bayer HealthCare’s Mark 7 Arterion angiographic contrast injector

There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives....

Nephrocheck Test System, Blood testing, contrast media

Ortho-Clinical Diagnostics Inc. announced the nationwide availability to hospitals of the Nephrocheck Test System designed to help healthcare providers identify patients at risk of developing...

Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients...

Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting. The enhanced version has new...

Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA) scientific assembly and annual meeting....

Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-dose compliant contrast medium...

The U.S. Food and Drug Administration (FDA) approved Lumason (sulfur hexafluoride lipid microsphere) for patients whose ultrasound image of the heart (echocardiograms) are hard to see with...

blood testing, nephrocheck

The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk...

Mallinckrodt U.S. Launch OptiSync Contrast Data Management System

Mallinckrodt announced the U.S. launch of the OptiSync data management system as a new technology in its Global Medical Imaging segment. 

September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in...

Imaging experts from the American Society of Echocardiography (ASE) released a paper, "Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from...

The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last...

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation...

Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.

Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in...

mri systems contrast media diamonds nanodiamonds cambridge

Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects of miniscule diamond fragments to harness their potential for precise quantum sensors in a...

GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension,...

No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue to aggressively pursue civil and...